Centre for Arab Genomic Studies officially opened at Al Wasl Hospital in Dubai yesterday. For the time being devoted to research budget of about million dirhams but will increase in the future. HE Hamad Abdul Rahman Al Cannon, Minister of Health, who opened the center to conduct genetic studies on the Arab population will be a key means to address a number of serious diseases, he said.
Center was established under the guidance of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai and UAE Minister of Finance and Industry patron Sheikh Hamdan Award for Medical Sciences in order to gather under one roof, a distinguished group of geneticists and research scientists from different Arab countries. Recent studies have shown that many human diseases have a genetic basis. The minister said: "In the Arab world, genetic diseases pose major public health problem due to the high percentage of inbreeding and a lack of public awareness." He added: "It will be the Centre for Arab Genomic Studies Forum which conducted participatory research and encourages and supports, and will also identify and explain the genetic basis of disease.
The center aims to raise the level of public awareness about the seriousness of genetic diseases and the importance of identifying disease-causing genes and develop a database of genetic diseases prevalent in the Arab world base. Cannon said: "We have to keep up with the latest scientific developments and be our contributions in this area; Moreover, the Arab scientists must come together and benefit from each other's experiences and global progress in this vital area."
The center will bring together diverse expertise and resources in the field of genetics together along with the relevant areas and promote understanding between experts and facilitate multi-disciplinary research through the support of qualified researchers highly qualified. The center will contribute to the prevention of genetic diseases by providing comprehensive services through the conversion of research achievements and translate them into an integrated treatment programs, and will collaborate with other research and medical institutions to ensure universal access to new findings and technical developments.